High Mobility Group Box 1 and Cardiovascular Diseases: Study of Act and Connect.

Autor: Wasim R; Department of Pharmacy, Integral University, Lucknow, 226026, India. rufaidaw@iul.ac.in.; Faculty of Pharmacy, Integral University, Lucknow, 226026, India. rufaidaw@iul.ac.in., Singh A; Department of Pharmacy, Integral University, Lucknow, 226026, India., Islam A; Department of Pharmacy, Integral University, Lucknow, 226026, India., Mohammed S; Department of Pharmacy, Integral University, Lucknow, 226026, India., Anwar A; Department of Pharmacy, Integral University, Lucknow, 226026, India., Mahmood T; Department of Pharmacy, Integral University, Lucknow, 226026, India.
Jazyk: angličtina
Zdroj: Cardiovascular toxicology [Cardiovasc Toxicol] 2024 Nov; Vol. 24 (11), pp. 1268-1286. Date of Electronic Publication: 2024 Sep 06.
DOI: 10.1007/s12012-024-09919-5
Abstrakt: Cardiovascular disease is the deadly disease that can result in sudden death, and inflammation plays an important role in its onset and progression. High mobility group box 1 (HMGB1) is a nuclear protein that regulates transcription, DNA replication, repair, and nucleosome assembly. HMGB1 is released passively by necrotic tissues and actively secreted by stressed cells. Extracellular HMGB1 functions as a damage associated molecular patterns molecule, producing numerous redox forms that induce a range of cellular responses by binding to distinct receptors and interactors, including tissue inflammation and regeneration. Extracellular HMGB1 inhibition reduces inflammation and is protective in experimental models of myocardial ischemia/reperfusion damage, myocarditis, cardiomyopathies caused by mechanical stress, diabetes, bacterial infection, or chemotherapeutic drugs. HMGB1 administration following a myocardial infarction followed by permanent coronary artery ligation improves cardiac function by stimulating tissue regeneration. HMGB1 inhibits contractility and produces hypertrophy and death in cardiomyocytes, while also stimulating cardiac fibroblast activity and promoting cardiac stem cell proliferation and differentiation. Maintaining normal nuclear HMGB1 levels, interestingly, protects cardiomyocytes from apoptosis by limiting DNA oxidative stress, and mice with HMGB1cardiomyocyte-specific overexpression are partially protected from cardiac injury. Finally, elevated levels of circulating HMGB1 have been linked to human heart disease. As a result, following cardiac damage, HMGB1 elicits both detrimental and helpful responses, which may be due to the formation and stability of the various redox forms, the particular activities of which in this context are mostly unknown. This review covers recent findings in HMGB1 biology and cardiac dysfunction.
(© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: